Top compounds associated with response to CPVL


Feature Type Standardized
Nominal ANOVA
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.1
mRNA SGX-523 CTRPv2 pan-cancer AAC -0.06 0.1
mRNA BMS-536924 CTRPv2 pan-cancer AAC 0.058 0.1
mRNA SR1001 CTRPv2 pan-cancer AAC 0.061 0.1
mRNA lenalidomide GDSC1000 pan-cancer AAC 0.059 0.1
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.052 0.1
mRNA lenalidomide FIMM pan-cancer AAC -0.3 0.1
mRNA FMK GDSC1000 pan-cancer AAC 0.061 0.1
mRNA WH-4-023 GDSC1000 pan-cancer AAC -0.088 0.1
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC 0.05 0.1
Download CSV